MediCardia is a technology company.
MediCardia has raised $4.0M across 2 funding rounds.
Key people at MediCardia.
MediCardia has raised $4.0M in total across 2 funding rounds.
MediCardia has raised $4.0M in total across 2 funding rounds.
MediCardia's investors include Cream City Venture Capital.
MediCardia Health is a Milwaukee-based digital health technology company that provides an intelligent platform for connected cardiovascular care. It collects, organizes, and analyzes data from wearables, home devices, implanted cardiac rhythm devices, and EHRs to enable remote patient monitoring (RPM), virtual care, and clinical decision support, optimizing physician time, improving outcomes, and supporting value-based care.[1][2][5]
The platform serves cardiologists, physicians, hospitals, care providers, patients, device manufacturers, and payers by triaging care gaps, predicting deteriorations, automating workflows, and integrating disparate data sources into a cardiology-focused EHR interface like HeartChart. It addresses heart disease—the leading U.S. health issue where 80% of premature events are preventable—by enabling proactive interventions, reducing costs, scaling clinic volumes, and enhancing efficiency through AI-driven insights and interoperability with systems like Epic and Cerner.[1][2][4]
MediCardia Health was founded in 2020 by Dr. Indrajit Choudhuri, MD, BSEE, who serves as CEO and brings over 15 years in cardiovascular operations, value-based care, EHR implementation, and informatics. In 2018, he prototyped the platform to aggregate data from EMRs, imaging, devices, wearables, and implants, using automation and AI for insights in value-based care transitions.[3][5]
Launched with funding from angel investor and Board Chair Jeff Rusinow, the company targeted digital transformation in cardiovascular disease for precision care. Key early team members include CFO/COO Maurizio Silenzi (tech ops experience at Motorola, Samsung, GE Healthcare) and others with expertise in cloud, DevSecOps, EHR interoperability, and medtech startups. Backed by Rusinow's track record of 60+ investments and exits like Propeller Health (acquired for $225M), MediCardia gained initial traction partnering with physicians and hospitals for RPM and connected care.[3][5]
MediCardia rides the digital health and value-based care wave, fueled by exploding unstructured health data from wearables/IoT, post-COVID virtual care adoption, and shifts to proactive chronic disease management—especially cardiology, where heart disease dominates U.S. mortality.[1][2][5]
Timing aligns with interoperability mandates, AI advancements, and payer pressures for outcomes/cost control; its platform influences the ecosystem by enabling data liquidity, clinician augmentation, and precision interventions, helping scale high-performance care amid clinician shortages.[2][5] As a convergence hub, it amplifies RPM providers and accelerates population health analytics, positioning cardiology for AI-driven personalization in a $4T+ U.S. healthcare market.
MediCardia is poised for expansion with its 2023 "Co-Pilot" AI enhancements, targeting broader chronic conditions beyond cardiology via generative AI for notes, plans, and interoperability.[5] Upcoming trends like multimodal AI, edge computing for devices, and federal incentives for RPM/value-based models will propel growth, potentially through partnerships or acquisitions akin to Rusinow's past exits.
Its influence may evolve as a backbone for connected care ecosystems, scaling precision health while sustaining momentum from prototype to production—exemplifying how targeted tech platforms transform cardiovascular outcomes in a data-rich era.[3][5]
Key people at MediCardia.
MediCardia has raised $4.0M across 2 funding rounds. Most recently, it raised $3.0M Series A in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2021 | $3.0M Series A | Cream City Venture Capital | |
| Feb 1, 2020 | $1.0M Seed | Cream City Venture Capital |
